AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Declaration of Voting Results & Voting Rights Announcements Jul 5, 2024

3091_iss_2024-07-05_914a0958-006d-482f-a377-62112cc6b367.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 04/07/2024
Limit for number of shares 5 %
After the transaction
Quantity
Shares 10,676,760
Directly held voting rights 0
Indirectly held voting rights 10,676,760
Percentage
Directly held shares 4.96163 %
Directly held voting rights 0 %
Indirectly held voting rights 5.04438 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.04438 % 10,676,760
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.04438 % 10,676,760
Chain
of
controlling
companies
Voting rights % Voting rights Company
10,371,566 4.90019 Nordnet Pensionsförsäkring AB
305,194
0.14419
Nordnet Livsforsikring AS
Group
total
holdings
Voting rights 10,676,760
Percentage of voting rights 5.04438
Published
05/07/2024 13:24
Contact
Name
Niklas Matses
Phone
0733854156 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.